(Q37758333)

22 August 2017

1 reference

title

Immunomodulatory effect of mesenchymal stem cells. (English)

1 reference

22 August 2017

main subject

mesenchymal stem cell

1 reference

C Herrero

1

1 reference

22 August 2017

J A Pérez-Simón

series ordinal

2

1 reference

22 August 2017

language of work or name

English

0 references

publication date

23 April 2010

1 reference

Brazilian Journal of Medical and Biological Research

22 August 2017

published in

1 reference

22 August 2017

volume

43

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

425-430

1 reference

Multilineage potential of adult human mesenchymal stem cells

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

21 January 2018

Mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

The stem cell niche in health and leukemic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Veto-Like Activity of Mesenchymal Stem Cells: Functional Discrimination Between Cellular Responses to Alloantigens and Recall Antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Human mesenchymal stem cells promote survival of T cells in a quiescent state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Myelodysplasic syndromes: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Switching cyclin D-Cdk4 kinase activity on and off.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2010007500033

10.1590/S0100-879X2010007500033

21 January 2018

Identifiers

DOI

1 reference

release_izv52zp5rndflbobmnerrx3ml4

22 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/izv52zp5rndflbobmnerrx3ml4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference